Guidelines Issued on Managing Infants Exposed to HIV
TUESDAY, Oct. 20, 2020 -- In a clinical report from the American Academy of Pediatrics, published online Oct. 19 in Pediatrics, guidelines are presented for the evaluation and management of infants exposed to HIV.
Ellen Gould Chadwick, M.D., from the Feinberg School of Medicine at Northwestern University in Chicago, and colleagues recommend maternal HIV infection be identified before or during pregnancy whenever possible. Routine HIV testing is recommended for all pregnant women, unless the patient declines testing. Expedited HIV antibody testing on the mother or newborn should be performed if the mother's HIV serostatus is unknown at the time of birth. For women living with HIV, avoidance of breastfeeding continues to be a strong recommendation.
The researchers also recommend pediatricians provide counseling about HIV infection to parents and caregivers of infants exposed to HIV, including counseling on routine care, diagnostic tests, and potential drug toxicities. Infants exposed to HIV should undergo virological testing at 14 to 21 days of age. If negative, these tests should be repeated at 1 to 2 and 4 to 6 months of age. Infants exposed to antiretroviral agents in utero should be monitored for drug toxicity. For infants exposed to HIV, immunizations and tuberculosis screening should be provided in accordance with published guidelines. Immediate family members of infants exposed to HIV should be offered HIV testing.
"We have come a long way in helping mothers manage perinatal HIV exposures to prevent transmission," Chadwick said in a statement. "We encourage open communication between doctors, patients and their families so that all appropriate therapies can be provided."
© 2020 HealthDay. All rights reserved.
Posted: October 2020
Read this next
WEDNESDAY, Nov. 25, 2020 -- From 2016 to 2019, there was an increase in prepregnancy obesity in the United States, according to a November data brief published by the U.S. Centers...
WEDNESDAY, Nov. 25, 2020 -- Less than one-third of infants born to mothers with hepatitis C virus infection (HCV+) receive appropriate HCV follow-up testing, according to a study...
TUESDAY, Nov. 24, 2020 -- COVID-19 infection during pregnancy does not appear to be associated with adverse maternal or neonatal outcomes, according to a study published online...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
- Monthly Update Archive
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.